Your browser is no longer supported. Please, upgrade your browser.
Settings
GBIO [NASD]
Generation Bio Co.
Index- P/E- EPS (ttm)-1.66 Insider Own20.10% Shs Outstand48.49M Perf Week-15.42%
Market Cap1.68B Forward P/E- EPS next Y-1.87 Insider Trans-5.62% Shs Float36.15M Perf Month10.88%
Income-80.50M PEG- EPS next Q-0.45 Inst Own82.00% Short Float12.24% Perf Quarter-12.58%
Sales- P/S- EPS this Y-63.70% Inst Trans6.57% Short Ratio9.19 Perf Half Y14.03%
Book/sh5.53 P/B5.45 EPS next Y2.10% ROA-30.10% Target Price43.33 Perf Year-
Cash/sh4.70 P/C6.41 EPS next 5Y- ROE-43.30% 52W Range17.00 - 55.72 Perf YTD6.38%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-45.87% Beta-
Dividend %- Quick Ratio23.90 Sales past 5Y- Gross Margin- 52W Low77.41% ATR2.36
Employees100 Current Ratio23.90 Sales Q/Q- Oper. Margin- RSI (14)42.85 Volatility9.19% 7.68%
OptionableYes Debt/Eq0.00 EPS Q/Q53.00% Profit Margin- Rel Volume0.56 Prev Close32.36
ShortableYes LT Debt/Eq0.00 EarningsMar 18 BMO Payout- Avg Volume481.36K Price30.16
Recom1.50 SMA20-6.79% SMA50-7.07% SMA200-0.43% Volume271,408 Change-6.80%
Feb-24-21Initiated William Blair Outperform
Feb-18-21Initiated Needham Buy $50
Jul-07-20Initiated Wedbush Outperform $31
Jul-07-20Initiated JP Morgan Overweight $28
Jul-07-20Initiated Jefferies Buy $38
Jul-07-20Initiated Cowen Outperform
Apr-27-21 04:35PM  
Apr-08-21 07:30AM  
Mar-21-21 05:20AM  
Mar-18-21 08:00AM  
Mar-01-21 08:53AM  
Feb-18-21 10:02AM  
07:30AM  
Jan-13-21 11:29PM  
Jan-11-21 05:43PM  
Jan-06-21 09:24PM  
Jan-05-21 08:44AM  
06:30AM  
Jan-04-21 06:30AM  
Dec-13-20 03:52AM  
Dec-02-20 11:34PM  
Nov-10-20 06:30AM  
Oct-31-20 08:00AM  
Oct-05-20 06:30AM  
Sep-24-20 06:30AM  
Sep-14-20 10:59AM  
Aug-11-20 06:30AM  
Aug-05-20 06:30AM  
Jul-22-20 07:00AM  
Jun-16-20 04:02PM  
Jun-12-20 12:31PM  
06:24AM  
Jun-11-20 09:52PM  
Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCDONOUGH GEOFFPRESIDENT AND CEOApr 23Sale35.1010,000351,0001,184,080Apr 27 04:02 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERApr 22Option Exercise4.592,50011,4752,500Apr 23 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 22Option Exercise0.601,500900199,654Apr 23 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 22Sale34.031,50051,045198,154Apr 23 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERApr 22Sale33.322,50083,3000Apr 23 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 21Option Exercise0.601,500900199,654Apr 23 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 21Sale31.071,50046,605198,154Apr 23 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 16Option Exercise0.601,500900199,654Apr 20 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 16Sale28.031,50042,045198,154Apr 20 04:05 PM
Rhodes Jason PDirectorApr 14Sale26.6123,413622,9950Apr 14 08:20 PM
ATLAS VENTURE ASSOCIATES X, L.10% OwnerApr 14Sale26.6123,413622,9950Apr 14 08:19 PM
Rhodes Jason PDirectorApr 13Sale25.1643,1451,085,74423,413Apr 14 08:20 PM
ATLAS VENTURE ASSOCIATES X, L.10% OwnerApr 13Sale25.1643,1451,085,74423,413Apr 14 08:19 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 12Option Exercise0.606,0003,600204,154Apr 14 04:01 PM
Rhodes Jason PDirectorApr 12Sale26.1574,1241,938,22966,558Apr 14 08:20 PM
ATLAS VENTURE ASSOCIATES X, L.10% OwnerApr 12Sale26.1574,1241,938,22966,558Apr 14 08:19 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 12Sale26.246,000157,446198,154Apr 14 04:01 PM
ATLAS VENTURE ASSOCIATES X, L.10% OwnerApr 09Sale27.6143,6811,205,948140,682Apr 09 08:54 PM
Rhodes Jason PDirectorApr 09Sale27.6143,6811,205,948140,682Apr 09 08:53 PM
ATLAS VENTURE ASSOCIATES X, L.10% OwnerApr 08Sale28.5043,5501,241,241184,363Apr 09 08:54 PM
Rhodes Jason PDirectorApr 08Sale28.5043,5501,241,241184,363Apr 09 08:53 PM
ATLAS VENTURE ASSOCIATES X, L.10% OwnerApr 07Sale28.5139,8641,136,671227,913Apr 09 08:54 PM
Rhodes Jason PDirectorApr 07Sale28.5139,8641,136,671227,913Apr 09 08:53 PM
Kerr DouglasCHIEF MEDICAL OFFICERApr 05Option Exercise5.1614,07272,612340,630Apr 07 04:05 PM
Kerr DouglasCHIEF MEDICAL OFFICERApr 05Sale30.0914,072423,451326,558Apr 07 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERMar 10Option Exercise0.6010,5006,300208,654Mar 12 04:03 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERMar 10Sale34.9710,500367,210198,154Mar 12 04:03 PM
Kerr DouglasCHIEF MEDICAL OFFICERMar 05Option Exercise4.5911,26751,716337,825Mar 09 04:05 PM
Kerr DouglasCHIEF MEDICAL OFFICERMar 05Sale31.4411,267354,267326,558Mar 09 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERMar 03Option Exercise4.593,00013,7703,000Mar 05 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERMar 03Sale41.383,000124,1400Mar 05 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERMar 01Option Exercise4.592,50011,4752,500Mar 03 04:10 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERMar 01Sale38.842,50097,0990Mar 03 04:10 PM
MCDONOUGH GEOFFPRESIDENT AND CEOMar 01Sale37.5810,000375,8011,194,080Mar 03 04:10 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERFeb 10Option Exercise0.6010,4006,240208,554Feb 12 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERFeb 10Sale34.6010,400359,856198,154Feb 12 04:05 PM
Kerr DouglasCHIEF MEDICAL OFFICERFeb 08Option Exercise4.5911,26751,716337,825Feb 10 04:05 PM
Kerr DouglasCHIEF MEDICAL OFFICERFeb 08Sale33.3711,267375,954326,558Feb 10 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERFeb 02Option Exercise4.592,50011,4752,500Feb 04 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERFeb 02Sale33.052,50082,6250Feb 04 04:05 PM
Angelino Mark D.CHIEF OPERATING OFFICERJan 15Option Exercise4.597,50034,425353,137Jan 20 04:05 PM
Angelino Mark D.CHIEF OPERATING OFFICERJan 15Sale32.977,500247,273345,637Jan 20 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJan 14Option Exercise0.605,6303,378203,784Jan 15 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERJan 14Option Exercise4.592,50011,4752,500Jan 15 04:06 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERJan 14Sale33.092,50082,7250Jan 15 04:06 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJan 14Sale32.545,630183,212198,154Jan 15 04:05 PM
Kerr DouglasCHIEF MEDICAL OFFICERJan 11Option Exercise4.5911,26751,716337,825Jan 13 04:07 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJan 11Option Exercise0.6014,8208,892212,974Jan 13 04:06 PM
Rowland Charles A JrDirectorJan 11Buy24.5020,408499,996101,035Jan 13 04:04 PM
Nicholson Donald WilliamDirectorJan 11Buy24.504,08199,984103,157Jan 13 04:05 PM
Kerr DouglasCHIEF MEDICAL OFFICERJan 11Sale27.5811,267310,768326,558Jan 13 04:07 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJan 11Sale27.6914,820410,372198,154Jan 13 04:06 PM
Angelino Mark D.Chief Operating OfficerDec 15Option Exercise4.595,30124,332350,938Dec 17 04:05 PM
Angelino Mark D.Chief Operating OfficerDec 15Sale34.985,301185,431345,637Dec 17 04:05 PM
Stanton MatthewChief Scientific OfficerDec 10Option Exercise0.6010,5406,324208,694Dec 14 04:05 PM
Stanton MatthewChief Scientific OfficerDec 10Sale37.6210,540396,499198,154Dec 14 04:05 PM
Angelino Mark D.Chief Operating OfficerAug 14Option Exercise0.6062,56037,536345,637Aug 18 04:07 PM